Log in to your Inderes Free account to see all free content on this page.
Nykode Therapeutics
1 investor is following this company
Nykode Therapeutics operates in biotechnology. The company is today specialized in the research and development of immunological therapies and vaccines. The solutions are mainly used for the treatment of patients with cancer and other serious health conditions that require long-term treatment. The main business of Nykode Therapeutics is found in the European market.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
NYKD
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
Interim report
21.08.2024
Interim report
27.11.2024
Annual report
26.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Rasmussengruppen AS | 9.2 % | 9.2 % |
Datum Opportunity AS | 8.0 % | 8.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
NYKD: Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting
NYKD: Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio